buprenorphine (as buprenorphine hydrochloride) 11.4 MG / naloxone (as naloxone hydrochloride dihydrate) 2.9 MG Sublingual Tablet

RxCUI: 1597568
RxNorm name: buprenorphine (as buprenorphine hydrochloride) 11.4 MG / naloxone (as naloxone hydrochloride dihydrate) 2.9 MG Sublingual Tablet
Display name: buprenorphine (as buprenorphine hydrochloride) 11.4 MG / naloxone (as naloxone hydrochloride dihydrate) 2.9 MG Sublingual Tablet
Full name: buprenorphine (as buprenorphine hydrochloride) 11.4 MG / naloxone (as naloxone hydrochloride dihydrate) 2.9 MG Sublingual Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zubsolv	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	Edenbridge Pharmaceuticals LLC.	57583c1d-9c44-4503-917d-68dba7377bd1	2026-06-12	Warnings, Adverse reactions	Exact identifier rxcui: 1597568
Zubsolv	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	Orexo US, Inc.	5f5cfcfe-d52b-49e6-8fe4-550477332dd2	2025-12-27	Warnings, Adverse reactions	Exact identifier rxcui: 1597568

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
5f5cfcfe-d52b-49e6-8fe4-550477332dd2	buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [PSN] · buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [SCD] · buprenorphine (as buprenorphine hydrochloride) 11.4 MG / naloxone (as naloxone hydrochloride dihydrate) 2.9 MG Sublingual Tablet [SY]	3	27	These highlights do not include all the information needed to use ZUBSOLV ® safely and effectively. See full prescribing information for ZUBSOLV. ZUBSOLV (buprenorphine and naloxone sublingual tablets), CIII Initial U.S. Approval: 2002	20251227